Statistical and graphical approaches for disproportionality analysis of spontaneously-reported adverse events in pharmacovigilance

被引:22
|
作者
Zink, Richard C. [1 ]
Huang Qin [2 ]
Zhang Lu-Yong [3 ]
Bao Wen-Jun [1 ]
机构
[1] SAS Inst Inc, Cary, NC USA
[2] SFDA, Ctr Drug Evaluat, Beijing 100053, Peoples R China
[3] China Pharmaceut Univ, Jiangsu Ctr Drug Screening, Nanjing 210009, Peoples R China
关键词
Disproportionality; Statistics; Graphics; Pharmacovigilance; Spontaneously-reported adverse events; SIGNAL GENERATION;
D O I
10.1016/S1875-5364(13)60035-7
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
AIM: Combine disproportionality analysis with dynamically interactive graphics to understand spontaneously-reported adverse events in pharmacovigilance. METHODS: Four statistical methods, including Reporting Odds Ratio, Proportional Reporting Ratio, Multi-Item Gamma Poisson Shrinker and Bayesian Confidence Propagation Neural Network that are used for computing disproportionality are described. Tree maps and other graphical techniques are used to display the disproportionality results. RESULTS: Spontaneously-reported adverse events in pharmacovigilance are collected from physicians, patients, or the medical literature by regulatory agencies, pharmaceutical companies and device manufacturers to monitor the safety of a product once it reaches the market. In order to identify potential safety-signals, disproportionality analysis methods compare the rate at which a particular event of interest co-occurs with a given drug with the rate this event occurs without the drug in the event database. Tree maps are employed to interactively display the adverse events for particular drugs and compare the adverse events among the drugs. CONCLUSIONS: Interactive graphical displays of disproportionality allow the analyst to quickly identify safety signals and perform additional follow-up analyses. Combining statistical methods with dynamically interactive graphics affords insights into the data inaccessible by traditional analysis methods.
引用
收藏
页码:314 / 320
页数:7
相关论文
共 50 条
  • [41] Novel adverse events of vortioxetine: A disproportionality analysis in USFDA adverse event reporting system database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Elsa
    ASIAN JOURNAL OF PSYCHIATRY, 2017, 30 : 152 - 156
  • [42] Fosfomycin-associated adverse events: A disproportionality analysis of the FDA Adverse Event Reporting System
    Yang, Luxuan
    Zhang, Wenyong
    Shen, Xiujuan
    Liu, Meiqin
    Wu, Meiying
    Xiao, Dan
    DRUG DISCOVERIES AND THERAPEUTICS, 2025,
  • [43] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Zou, Shu-peng
    Yang, Hai-yun
    Ouyang, Meng-ling
    Cheng, Qian
    Shi, Xuan
    Sun, Ming-hui
    BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [44] Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)
    Xiong, Xiaomei
    Zhang, Xiuwen
    Li, Xiaoxia
    Huang, Taomin
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (11) : 1447 - 1452
  • [45] Cardiac adverse events associated with quetiapine: Disproportionality analysis of FDA adverse event reporting system
    Shu, Yamin
    Ding, Yiling
    Liu, Lulu
    Zhang, Qilin
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (09) : 2705 - 2716
  • [46] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Shu-peng Zou
    Hai-yun Yang
    Meng-ling Ouyang
    Qian Cheng
    Xuan Shi
    Ming-hui Sun
    BMC Pharmacology and Toxicology, 24
  • [47] Novel adverse events of blonanserin: a disproportionality analysis in the FDA Adverse Event Reporting System database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Thomas
    MINERVA PSICHIATRICA, 2018, 59 (02): : 105 - 110
  • [48] Collaboration between toxicology laboratory and pharmacovigilance centre: detection of non-spontaneously reported adverse effects
    Billet, K.
    Pageot, C.
    Bouchet, S.
    Molimard, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 : 61 - 61
  • [49] Collaboration between toxicology laboratory and pharmacovigilance centre: detection of non-spontaneously reported adverse effects
    Bopp, W.
    Rousset, M.
    Bouchet, S.
    Miremont-Salame, G.
    Molimard, M.
    Pariente, A.
    Pageot, C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 32 - 32
  • [50] Analysis of Reported Adverse Events Related to Hemospray
    Ahmed, Khalid
    Abdallah, Mohamed
    Abbas, Daniyal
    Jaber, Fouad
    Abdalla, Abubaker O.
    Mohamed, Mouhand
    Mcdonald, Nicholas
    Hanson, Brian J.
    Bilal, Mohammad
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (04) : 402 - 406